1. "MSK Grad Students"
  2. "Doris Ponce"
  3. "Transplantation and Cellular Therapy"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
  3. Guidelines (1)
Groups
  1. Bone Marrow Transplant (14)
  2. CTCR Scholars (14)
  3. Center for Hematologic Malignancies (14)
  4. Department of Medicine (14)
  5. Hematologic Malignancies, Division of (14)
  6. MSK Grad Students (14)

More Groups

People
  1. Doris Ponce (14)
  2. Miguel-Angel Perales (12)
  3. Sergio Giralt (9)
  4. Parastoo Dahi (8)
  5. Brian Shaffer (7)
  6. Sean Devlin (7)

More People

Years
  1. 2024 (1)
  2. 2022 (8)
  3. 2021 (5)
Publications
  1. Transplantation and Cellular Therapy (14)
Publishers
  1. Elsevier Inc. (14)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Racial disparities in access to alternative donor allografts persist in the era of “Donors for all”
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim results of a pilot, prospective, randomized, double-blinded, vehicle-controlled trial on safety and efficacy of a topical inhibitor of Janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non-sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease
    Meeting Abstract

    Markova, A.; Prockop, S. E.; Dusza, S.; Pan, A.; Chowdhury, A.; Lacouture, M. E.; Perales, M. A.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Post-transplant Cyclophosphamide (PTCy) is associated with superior gvhd-free, relapse-free survival (GRFS) in HLA-mismatched unrelated donor (MMUD) hematopoietic cell transplantation
    Meeting Abstract

    Jimenez, A. M. J; Perales, M. A.; Devlin, S. M.; Brown, S.; Lekakis, L. J.; Sauter, C. S.; Pereira, D.; Wang, T. P.; Ponce, D. M.; Beitinjaneh, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Double unit cord blood transplantation compares favorably to T-cell depleted matched adult donor transplantation for the treatment of acute leukemia due to a robust protection against relapse
    Meeting Abstract

    Politikos, I.; Flynn, J.; Devlin, S. M.; Fingrut, W.; Maloy, M. A.; Naputo, K.; Chinapen, S.; Rodriguez, N. T.; Quach, S.; Dominguez, Y.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Noninvasive genomic characterization of patients with nonsclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease identified a novel gene signature in responders to ruxolitinib cream
    Meeting Abstract

    Markova, A.; Whitaker, J. W.; Ai, R.; Pan, A.; Dusza, S.; Lacouture, M. E.; Chowdhury, A.; Perales, M. A.; Prockop, S. E.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Real-time reflectance confocal microscopy of cutaneous graft-versus-host disease correlates with histopathology
    Journal Article

    Reingold, R. E.; Monnier, J.; Ardigò, M.; Stoll, J. R.; Pena, M. C.; Nanda, J. K.; Dusza, S. W.; Ruiz, J. D.; Flynn, L.; Afrin, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation is feasible in patients with prior COVID-19 infection
    Journal Article

    Shah, N.; Dahi, P. B.; Ponce, D. M.; Sauter, C. S.; Shaffer, B. C.; Chung, D. J.; Politikos, I.; Lin, R. J.; Giralt, S. A.; Papanicolaou, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Oral proteasome inhibitor ixazomib for switch-maintenance prophylaxis of recurrent or late acute and chronic graft-versus-host disease after day 100 in allogeneic stem cell transplantation
    Journal Article

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S. M.; Soto, C.; Cho, C.; Dahi, P.; Giralt, S.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save